Identification and distribution of Achromobacter species in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 12, Issue 3, 2013, Pages 298-301

  Spilker, Theodore ^a   Vandamme, Peter ^b   LiPuma, John J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Achromobacter; Clinical microbiology; Infection; Taxonomy

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; NRDA PROTEIN; UNCLASSIFIED DRUG;

ACHROMOBACTER; ACHROMOBACTER MARPLATENSIS; ACHROMOBACTER PIECHAUDII; ACHROMOBACTER RUHLANDII; ACHROMOBACTER XYLOSOXIDANS; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CYSTIC FIBROSIS; GENE LOCUS; MULTILOCUS SEQUENCE TYPING; NONHUMAN; SEQUENCE ANALYSIS; SPECIES DIFFERENCE; SPECIES DISTRIBUTION; SPECIES IDENTIFICATION;

ACHROMOBACTER; BACTERIAL PROTEINS; CYSTIC FIBROSIS; DNA, BACTERIAL; HUMANS;

EID: 84876973969     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.10.002     Document Type: Article

References (18)

1. LiPuma J.J. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 2010, 23:299-323.
2. Coenye T., Vancanneyt M., Cnockaert M.C., Falsen E., Swings J., Vandamme P. Kerstersia gyiorum gen. nov., sp. nov., a novel Alcaligenes faecalis-like organism isolated from human clinical samples, and reclassification of Alcaligenes denitrificans Ruger and Tan 1983 as Achromobacter denitrificans comb. nov. Int J Syst Evol Microbiol 2003, 53:1825-1831.
3. Coenye T., Vancanneyt M., Falsen E., Swings J., Vandamme P. Achromobacter insolitus sp. nov. and Achromobacter spanius sp. nov., from human clinical samples. Int J Syst Evol Microbiol 2003, 53:1819-1824.
4. Gomila M., Tvrzová L., Teshim A., Sedlácek I., González-Escalona N., Zdráhal Z., et al. Achromobacter marplatensis sp. nov., isolated from a pentachlorophenol-contaminated soil. Int J Syst Evol Microbiol 2011, 61:2231-2237.
5. Kiredjian M., Holmes B., Kersters K., Guilvout I.De, Ley J. Alcaligenes piechaudii, a new species from human clinical specimens and the environment. Int J Syst Evol Microbiol 1986, 36:282-287.
6. Spilker T., Vandamme P., LiPuma J.J. An Achromobacter multilocus sequence typing scheme infers population structure and reveals several putative novel Achromobacter species. J Clin Microbiol Jul. 11 2012, 50:3010-3015. [Epub ahead of print].
7. Jolley K.A., Maiden M.C.J. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 2010, 11:595.
8. Palys T., Nakamura L.K., Cohan F.M. Discovery and classification of ecological diversity in the bacterial world: the role of DNA sequence data. Int J Syst Bacteriol 1997, 47:1145-1156.
9. Ridderberg W., Wang M., Nørskov-Lauritsen N. Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans. J Clin Microbiol 2012, 50:2688-2694.
10. Cystic Fibrosis Foundation Cystic Fibrosis Foundation patient registry. Annual data report 2010, Cystic Fibrosis Foundation, Bethesda, Maryland.
11. Yabuuchi E., Kawamura Y., Kosako Y., Ezaki T. Emendation of genus Achromobacter and Achromobacter xylosoxidans (Yabuuchi and Yano) and proposal of Achromobacter ruhlandii (Packer and Vishniac) comb. nov., Achromobacter piechaudii (Kiredjian et al.) comb. nov., and Achromobacter xylosoxidans subsp. denitrificans (Rüger and Tan) comb. nov. Microbiol Immunol 1998, 42:429-438.
12. Rønne Hansen C., Pressler T., Høiby N., Gormsen M. Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study. J Cyst Fibros 2006, 5:245-251.
13. Ridderberg W., Bendstrup K.E., Olesen H.V., Jensen-Fangel S., Nørskov-Lauritsen N. Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment. J Cyst Fibros 2011, 10:466-469.
14. De Baets F., Schelstraete P., Van Daele S., Haerynck F., Vaneechoutte M. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J Cyst Fibros 2007, 6:75-78.
15. Raso T., Bianco O., Grosso B., Zucca M., Savoia D. Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients. APMIS 2008, 116:837-841.
16. Lambiase A., Catania M.R., Del Pezzo M., Rossano F., Terlizzi V., Sepe A., et al. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 2011, 30:973-980.
17. McPhail G.L., VanDyke R., Fenchel M., LiPuma J.J., Joseph P.M. An update on clinical outcomes associated with a clonal strain of Achromobacter (Alcaligenes) xylosoxidans. Pediatr Pulm 2009, (Suppl. 32):310.
18. Magni A., Trancassini M., Varesi P., Iebba V., Curci A., Pecoraro C., et al. Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features of cystic fibrosis patients. J Clin Microbiol 2010, 48:1035-1039.